DCLA
LLY icon

Douglas C. Lane & Associates’s Eli Lilly LLY Stock Holding History

Douglas C. Lane & Associates’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$656K Sell
7,790
-3,028
-28% -$251K 0.02% 163
2015
Q3 		$905K Buy
10,818
+5,698
+111% +$481K 0.03% 153
2015
Q2 		$427K Sell
5,120
-100
-2% -$7.62K 0.01% 180
2015
Q1 		$379K Buy
5,220
+1,928
+59% +$137K 0.01% 188
2014
Q4 		$227K Buy
3,292
+30
+0.9% +$2.02K 0.01% 214
2014
Q3 		$212K Buy
+3,262
New +$207K 0.01% 210

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Douglas C. Lane & Associates's LLY Position: Q4 2015 in Review

Douglas C. Lane & Associates reduced its Eli Lilly (LLY) stake by 28% in Q4 2015, selling an estimated $251K and leaving 7,790 shares worth $656K. The position accounts for 0.02% of the portfolio, ranked #163.

Douglas C. Lane & Associates first reported a position in LLY in Q3 2014 and has held it in 6 quarters since. The position peaked at $905K in Q3 2015. 1,221 funds tracked by Wall St. Rank hold LLY as of Q4 2015.

  • Douglas C. Lane & Associates held 7,790 shares of Eli Lilly worth $656K as of Q4 2015.
  • Douglas C. Lane & Associates sold 3,028 Eli Lilly shares in Q4 2015, an estimated $251K.
  • Eli Lilly made up 0.02% of Douglas C. Lane & Associates's portfolio in Q4 2015, its #163 holding.
  • Douglas C. Lane & Associates first reported a position in Eli Lilly in Q3 2014 and has held it in 6 quarters since.
  • Douglas C. Lane & Associates's Eli Lilly position peaked at $905K in Q3 2015.
  • 1,221 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2015.

Based on Douglas C. Lane & Associates's 13F filing for Q4 2015, filed 25 Jan 2016.